| Date | Product | Disease | Phase | Company | Therapeutic area |
|---|---|---|---|---|---|
| 2015-11-03 | BI 1482694 (HM61713) | T790M mutation-positive non-small cell lung cancer (NSCLC), whose tumours stopped responding to currently available epidermal growth factor receptor (EGFR) directed therapies | 2 | Boehringer Ingelheim (Germany) | Cancer - Oncology |
| 2015-11-03 | atesidorsen (COR-004 -ATL1103 - 2'-O-(2-methoxyethyl) phosphorothioate antisense oligonucleotide targeting the growth hormone receptor) | acromegaly | 2 | Strongbridge Biopharma (Ireland) previously known as Cortendo (Sweden) | Rare diseases - Hormonal diseases - Endocrine diseases |
| 2015-11-03 | evofosfamide (TH-302) and immune checkpoint inhibitors | preclinical | Threshold Pharmaceuticals (USA - CA) | Cancer - Oncology | |
| 2015-11-02 | NVP015 - Complex I Deficiency discovery program including succinate prodrug candidates | mitochondrial disorders associated with complex I deficiency such as Leigh Syndrome | preclinical | Neurovive Pharmaceutical (Sweden) | Rare diseases - Neurodegenerative diseases |
| 2015-11-02 | tissue engineered replacement trachea | severe structural airway disease (SSAD) | 1 | Videregen (UK) | Respiratory diseases - Regenerative medicine |
| 2015-11-02 | VSN16R | spasticity caused by multiple sclerosis | 2 | Canbex Therapeutics (UK) | Neurodegenerative diseases |
| 2015-11-02 | NI-0101 ( anti-TLR4 ( toll-like receptor-4) monoclonal antibody) | rheumatoid arthritis | 2 | NovImmune (Switzerland) | Autoimmune diseases – Inflammatory diseases - Rheumatic diseases |
| 2015-11-02 | Keytruda® (pembrolizumab) | colorectal carcinoma | 3 | Merck&Co (USA - NJ) | Cancer - Oncology |
| 2015-11-02 | afatinib | non-small cell lung cancer (NSCLC) | 2 | Boehringer Ingelheim (Germany) | Cancer - Oncology |
| 2015-10-31 | GZ402668 | progressive multiple sclerosis | 1 | Genzyme (USA - MA), a Sanofi company (France) | Autoimmune diseases - Neurodegenerative diseases |
| 2015-10-29 | GTL001 (ProCervix®) | treatment of adult women already infected with human papillomavirus (HPV) genotype 16 or 18 | 1 | Genticel (France) | Cancer - Oncology - Infectious diseases |
| 2015-10-29 | ALKS 8700 (monomethyl fumarate) | multiple sclerosis | 1 | Alkermes (Ireland) | Neurodegenerative diseases |
| 2015-10-29 | crisaborole topical ointment (AN2728) | mild-to-moderate atopic dermatitis | 3 | Anacor Pharmaceuticals (US - CA) | Dermatological diseases - Inflammatory diseases |
| 2015-10-29 | AZP-531 (unacylated ghrelin analog) | type 2 diabete, Prader-Willi syndrome | 1b | Alize Pharma (France) | Metabolic diseases |
| 2015-10-29 | PBI-4050 - 3-pentylbenzenacetic acid sodium salt | 2 | ProMetic Life Sciences (Canada) | Metabolic diseases | |
| 2015-10-29 | denintuzumab mafodotin (SGN-CD19A) in combination with the second-line salvage regimen of rituximab (Rituxan®), ifosfamide, carboplatin and etoposide (RICE) | relapsed or refractory diffuse large B-cell lymphoma (DLBCL) or Grade 3b follicular lymphoma | 2 | Seattle Genetics (USA - WA) | Cancer - Oncology |
| 2015-10-29 | rivipansel (GMI-1070) | 1 | GlycoMimetics (USA - Md) | Cancer - Oncology | |
| 2015-10-29 | SAR438335 | diabetes | 1 | Sanofi (France) | Metabolic diseases |
| 2015-10-28 | sNN0031 | Parkinson’s disease | 2 | Newron Pharmaceuticals (Italy) | Neurodegenerative diseases |
| 2015-10-28 | sNN0029 | amyotrophic lateral sclerosis | 2 | Newron Pharmaceuticals (Italy) | Neurodegenerative diseases - Rare diseases |
